Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Mary Beth Fritz Sells 9,885 Shares

Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Mary Beth Fritz sold 9,885 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total transaction of $810,273.45. Following the completion of the transaction, the senior vice president now directly owns 18,835 shares in the company, valued at $1,543,904.95. This represents a 34.42 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Prestige Consumer Healthcare Stock Performance

PBH opened at $82.36 on Friday. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61. The business’s 50 day moving average is $73.13 and its 200-day moving average is $70.18. The stock has a market cap of $4.07 billion, a PE ratio of 20.04, a price-to-earnings-growth ratio of 2.32 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a twelve month low of $56.61 and a twelve month high of $83.83.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting the consensus estimate of $1.09. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The firm had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. During the same quarter in the previous year, the business earned $1.07 EPS. The firm’s revenue for the quarter was down .9% on a year-over-year basis. On average, analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Institutional Investors Weigh In On Prestige Consumer Healthcare

Several institutional investors have recently bought and sold shares of the stock. State Board of Administration of Florida Retirement System increased its stake in Prestige Consumer Healthcare by 77.4% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock valued at $1,830,000 after buying an additional 11,000 shares during the period. Lombard Odier Asset Management USA Corp bought a new stake in Prestige Consumer Healthcare during the second quarter worth approximately $550,000. CANADA LIFE ASSURANCE Co raised its holdings in Prestige Consumer Healthcare by 19.4% during the first quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock worth $3,453,000 after purchasing an additional 7,715 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in Prestige Consumer Healthcare by 12.9% in the third quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock worth $708,000 after purchasing an additional 1,120 shares during the period. Finally, Atria Investments Inc bought a new position in Prestige Consumer Healthcare during the 1st quarter valued at $1,246,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Analyst Upgrades and Downgrades

PBH has been the topic of a number of research reports. Jefferies Financial Group reiterated a “hold” rating and set a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. DA Davidson reiterated a “buy” rating and issued a $95.00 target price on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. One analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and an average price target of $83.67.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.